US Patent 7157447 Bicyclic heterocycles as HIV integrase inhibitors

Patent 7157447 was granted and assigned to Bristol-Myers Squibb on January, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71574470

Patent Inventor Names

Yasutsugu Ueda0

Roger Remillard0

Serge Plamondon0

Timothy P. Connolly0

B. Narasimhulu Naidu0

Carl Ouellet0

Francis Beaulieu0

Jacques Banville0

...

Date of Patent

January 2, 2007

Patent Application Number

112885330

Date Filed

November 29, 2005

Patent Primary Examiner

‌

Mark Berch

Patent abstract

The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7157447 Bicyclic heterocycles as HIV integrase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API